John A. Turton

1.4k total citations
42 papers, 1.1k citations indexed

About

John A. Turton is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, John A. Turton has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Oncology. Recurrent topics in John A. Turton's work include Aldose Reductase and Taurine (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Biochemical effects in animals (5 papers). John A. Turton is often cited by papers focused on Aldose Reductase and Taurine (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Biochemical effects in animals (5 papers). John A. Turton collaborates with scholars based in United Kingdom, United States and Mexico. John A. Turton's co-authors include Catherine J. Waterfield, John A. Timbrell, Alexander T. Florence, Ijeoma F. Uchegbu, John A. Double, William J. Griffiths, Kevin J. Randall, John R. Foster, Malcolm J. York and Yuqin Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Journal of Lipid Research.

In The Last Decade

John A. Turton

42 papers receiving 1.1k citations

Peers

John A. Turton
Min S. Chang United States
Scott J. Weir United States
Christopher P. Thomas United Kingdom
Clarence L. Young United States
J.M. te Koppele Netherlands
Rowan F. van Golen Netherlands
Min S. Chang United States
John A. Turton
Citations per year, relative to John A. Turton John A. Turton (= 1×) peers Min S. Chang

Countries citing papers authored by John A. Turton

Since Specialization
Citations

This map shows the geographic impact of John A. Turton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Turton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Turton more than expected).

Fields of papers citing papers by John A. Turton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Turton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Turton. The network helps show where John A. Turton may publish in the future.

Co-authorship network of co-authors of John A. Turton

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Turton. A scholar is included among the top collaborators of John A. Turton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Turton. John A. Turton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Randall, Kevin J., John A. Turton, & John R. Foster. (2011). Explant culture of gastrointestinal tissue: a review of methods and applications. Cell Biology and Toxicology. 27(4). 267–284. 78 indexed citations
2.
Al‐Jamal, Khuloud T., Wafa’ T. Al-Jamal, Kostas Kostarelos, John A. Turton, & Alexander T. Florence. (2011). Anti-angiogenic poly-L-lysine dendrimer binds heparin and neutralizes its activity. PubMed. 2. 9–15. 20 indexed citations
3.
Karu, Kersti, John A. Turton, Yuqin Wang, & William J. Griffiths. (2011). Nano-liquid chromatography–tandem mass spectrometry analysis of oxysterols in brain: monitoring of cholesterol autoxidation. Chemistry and Physics of Lipids. 164(6). 411–424. 33 indexed citations
4.
Al‐Jamal, Khuloud T., Wafa’ T. Al-Jamal, Simon Akerman, et al.. (2011). Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Research Explorer (The University of Manchester). 70 indexed citations
5.
Munday, Michael R., et al.. (2009). Dose response and time course studies on superoxide dismutase as a urinary biomarker of carbon tetrachloride‐induced hepatic injury in the Hanover Wistar rat. International Journal of Experimental Pathology. 90(5). 500–511. 3 indexed citations
6.
Pearse, Gail, et al.. (2009). Time-course Study of the Immunotoxic Effects of the Anticancer Drug Chlorambucil in the Rat. Toxicologic Pathology. 37(7). 887–901. 5 indexed citations
7.
Molyneux, Gemma, et al.. (2008). The haemotoxicity of azathioprine in repeat dose studies in the female CD‐1 mouse. International Journal of Experimental Pathology. 89(2). 138–158. 17 indexed citations
8.
Molyneux, Gemma, et al.. (2008). Serum FLT‐3 ligand in a busulphan‐induced model of chronic bone marrow hypoplasia in the female CD‐1 mouse. International Journal of Experimental Pathology. 89(2). 159–170. 13 indexed citations
10.
Karu, Kersti, Martin Hornshaw, Gary Woffendin, et al.. (2007). Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. Journal of Lipid Research. 48(4). 976–987. 89 indexed citations
11.
Turton, John A., William R. Sones, C. M. Andrews, et al.. (2006). Further development of a model of chronic bone marrow aplasia in the busulphan‐treated mouse. International Journal of Experimental Pathology. 87(1). 49–63. 14 indexed citations
12.
Cristofori, Patrizia, Federica Crivellente, Mario Campagnola, et al.. (2004). Reduced progression of atherosclerosis in apolipoprotein E‐deficient mice treated with lacidipine is associated with a decreased susceptibility of low‐density lipoprotein to oxidation. International Journal of Experimental Pathology. 85(2). 105–114. 7 indexed citations
13.
Pilling, Andrew, et al.. (2004). Expression of somatostatin mRNA and peptides in C‐cell tumours of the thyroid gland in Han Wistar rats. International Journal of Experimental Pathology. 85(1). 13–23. 3 indexed citations
14.
Gibson, Frances M., C. M. Andrews, Paraskevi Diamanti, et al.. (2003). A new model of busulphan‐induced chronic bone marrow aplasia in the female BALB/c mouse. International Journal of Experimental Pathology. 84(1). 31–48. 17 indexed citations
15.
Turton, John A., et al.. (1999). Preparation and In Vitro/In Vivo Evaluation of Luteinizing Hormone Releasing Hormone (LHRH)-Loaded Polyhedral and Spherical/Tubular Niosomes. Journal of Pharmaceutical Sciences. 88(1). 34–38. 46 indexed citations
16.
Uchegbu, Ijeoma F., John A. Double, John A. Turton, & Alexander T. Florence. (1995). Distribution, Metabolism and Tumoricidal Activity of Doxorubicin Administered in Sorbitan Monostearate (Span 60) Niosomes in the Mouse. Pharmaceutical Research. 12(7). 1019–1024. 70 indexed citations
17.
Uchegbu, Ijeoma F., John A. Turton, John A. Double, & Alexander T. Florence. (1994). Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouse. Biopharmaceutics & Drug Disposition. 15(8). 691–707. 16 indexed citations
18.
Waterfield, Catherine J., et al.. (1993). Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats. Archives of Toxicology. 67(4). 244–254. 93 indexed citations
19.
Waterfield, Catherine J., et al.. (1993). Reduction of liver taurine in rats by β-alanine treatment increases carbon tetrachloride toxicity. Toxicology. 77(1-2). 7–20. 46 indexed citations
20.
Waterfield, Catherine J., et al.. (1993). The correlation between urinary and liver taurine levels and between pre-dose urinary taurine and liver damage. Toxicology. 77(1-2). 1–5. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026